Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,126.06
(
1.20%
)
US TECH 100
25,958.80
(
1.33%
)
Dow Jones
49,447.43
(
1.88%
)
Brent Oil
91.54
(
-1.21%
)
Bitcoin
74,408.62
(
0.74%
)
News Focus
News Focus
Post# of 1166
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BottomBounce

Send PM Follow Ignore
Followers 926
Posts 158368
Boards Moderated 2
Alias Born 08/13/2010

BottomBounce

Member Level

Re: BUFCARP post# 938

Monday, 08/16/2021 6:08:11 PM

Monday, August 16, 2021 6:08:11 PM

Post# of 1166
$CEMI Chembio Diagnostics Got a FDA Emergency Use Nod For Its COVID-19 Antibody Test

The FDA has granted emergency use authorization to Chembio Diagnostics Inc's (NASDAQ: CEMI) COVID-19 antibody test.
The nod comes for LumiraDx SARS-CoV-2 Ab Test, a microfluidic immunofluorescence assay for the qualitative detection of total antibodies in whole human blood, plasma, or serum for indication of recent or prior infection.
Recently, the Company received a $28 million order to supply DPP SARS-CoV-2 Antigen tests for delivery during 2021 in Brazil.

Nothing I say, post, or do should ever be considered financial advice. I may be holding a long, short or no position. I am NOT or NEVER have I been compensated to post on here or anywhere and all my posts are for entertainment purposes only.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CEMI News
More CEMI News